ARRAY BIOPHARMA INC's ticker is ARRY and the CUSIP is 04269X105. A total of 2 filers reported holding ARRAY BIOPHARMA INC in Q3 2019. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2019 | $10,171,000 | +60.5% | 219,535 | -15.6% | 2.14% | +52.7% |
| Q1 2019 | $6,339,000 | +54.6% | 260,000 | -9.6% | 1.40% | +37.2% |
| Q4 2018 | $4,099,000 | +34.8% | 287,631 | +43.8% | 1.02% | +64.0% |
| Q3 2018 | $3,040,000 | -27.5% | 200,000 | -20.0% | 0.62% | -32.4% |
| Q2 2018 | $4,195,000 | +2.8% | 250,000 | 0.0% | 0.92% | +1.8% |
| Q1 2018 | $4,080,000 | +27.5% | 250,000 | 0.0% | 0.91% | +27.8% |
| Q4 2017 | $3,200,000 | +173.7% | 250,000 | +163.2% | 0.71% | +157.8% |
| Q3 2017 | $1,169,000 | +47.0% | 95,000 | 0.0% | 0.28% | +37.5% |
| Q2 2017 | $795,000 | – | 95,000 | – | 0.20% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Redmile Group, LLC | 16,618,776 | $146,079,000 | 12.59% |
| BVF INC/IL | 4,986,186 | $43,829,000 | 8.81% |
| First Light Asset Management, LLC | 1,000,361 | $8,793,000 | 3.86% |
| Crosspoint Capital Strategies, LLC | 463,005 | $4,070,000 | 3.62% |
| Consonance Capital Management LP | 2,723,471 | $23,912,000 | 2.63% |
| KOPP INVESTMENT ADVISORS LLC | 219,926 | $1,933,000 | 2.04% |
| SPHERA FUNDS MANAGEMENT LTD. | 900,000 | $7,911,000 | 2.00% |
| Orbimed Advisors | 16,088,800 | $141,421,000 | 1.80% |
| Cormorant Asset Management, LP | 1,150,000 | $10,109,000 | 1.36% |
| BOGLE INVESTMENT MANAGEMENT L P /DE/ | 2,073,680 | $18,227,000 | 1.26% |